In the past 50 years, the survival rate for pancreatic cancer has only improved by 10%. This is not meaningful progress, and patients cannot rely on hope alone to live through this deadly disease. Pancreatic Cancer North America aims to disrupt the traditional approach to discovery in pancreatic cancer by bringing together multiple sectors, innovations, and novel methods to drive real change. We are committed to working with all partners who believe as we do in coming together boldly to change the outcome for the world’s toughest cancer.